President and CEO of Tracon Pharmaceuticals, Inc. (NASDAQ:TCON), Theuer Charles, buys 1,000 shares worth $9,980
According to Tracon Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:00 AM, company President and CEO, Theuer Charles disclosed buying 1,000 shares at a cost of $9.98. At the time of this transaction (Dec 29), this trade was worth $9,980 in total. As of Dec 29, Theuer Charles now owns 190,232 shares in total worth about $2,024,068.4800000002.
For the last few recent trades made by Tracon Pharmaceuticals, Inc. (NASDAQ:TCON) President and CEO, Theuer Charles, we have the following information:
- SEC Form 4 filing: Oct 21: Bought 2,000 shares at the rate of $4.38 per share. Total worth of this trade was $8,769. Total number of shares owned as of Oct 21 were 189,232
- SEC Form 4 filing: Sep 23: Bought 5,000 shares at the rate of $4.72 per share. Total worth of this trade was $23,599. Total number of shares owned as of Sep 23 were 186,882
- SEC Form 4 filing: Sep 04: Bought 10,000 shares at the rate of $2.58 per share. Total worth of this trade was $25,750. Total number of shares owned as of Sep 04 were 181,882
Posted by
George Daniels
on Wednesday December 30 2020, 10:02 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
